ClinicaliQ Trial Snapshot
- MEASuRE: Metreleptin Effectiveness And Safety Registry — Recruiting • NCT02325674.
- A registry tracking safety and effectiveness of metreleptin treatment in patients across the US and Europe.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The study is a post-authorization, prospective, voluntary registry of patients treated with commercial metreleptin including, but not limited to, patients in the US and EEA. Conditions: Generalised Lipodystrophy, Partial Lipodystrophy Interventions: Metreleptin Lead Sponsor: Chiesi Farmaceutici S.p.A. Planned Enrollment: 100 participants